DE69034037D1 - Verfahren zur Herstellung von TGF-beta - Google Patents

Verfahren zur Herstellung von TGF-beta

Info

Publication number
DE69034037D1
DE69034037D1 DE69034037T DE69034037T DE69034037D1 DE 69034037 D1 DE69034037 D1 DE 69034037D1 DE 69034037 T DE69034037 T DE 69034037T DE 69034037 T DE69034037 T DE 69034037T DE 69034037 D1 DE69034037 D1 DE 69034037D1
Authority
DE
Germany
Prior art keywords
tgf
sup
cation exchange
reactor
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69034037T
Other languages
English (en)
Other versions
DE69034037T2 (de
Inventor
Pungaor, Jr
Eirik Nestaas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Publication of DE69034037D1 publication Critical patent/DE69034037D1/de
Application granted granted Critical
Publication of DE69034037T2 publication Critical patent/DE69034037T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02Separating microorganisms from the culture medium; Concentration of biomass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE69034037T 1989-09-11 1990-09-10 Verfahren zur Herstellung von TGF-beta Expired - Fee Related DE69034037T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/405,695 US5043431A (en) 1989-09-11 1989-09-11 Method and apparatus for the production of TGF-β

Publications (2)

Publication Number Publication Date
DE69034037D1 true DE69034037D1 (de) 2003-02-20
DE69034037T2 DE69034037T2 (de) 2003-08-28

Family

ID=23604819

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69027995T Expired - Lifetime DE69027995T2 (de) 1989-09-11 1990-09-10 Reinigungsverfahren von transformierendem wachstumsfaktor (tgf)
DE69034037T Expired - Fee Related DE69034037T2 (de) 1989-09-11 1990-09-10 Verfahren zur Herstellung von TGF-beta

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69027995T Expired - Lifetime DE69027995T2 (de) 1989-09-11 1990-09-10 Reinigungsverfahren von transformierendem wachstumsfaktor (tgf)

Country Status (10)

Country Link
US (2) US5043431A (de)
EP (4) EP1104807A2 (de)
JP (1) JPH05500898A (de)
AT (2) ATE231165T1 (de)
AU (1) AU6504490A (de)
CA (1) CA2066576A1 (de)
DE (2) DE69027995T2 (de)
DK (2) DK0491849T3 (de)
ES (2) ES2188632T3 (de)
WO (1) WO1991004267A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221734A (en) * 1987-10-01 1993-06-22 Ciba-Geigy Corporation Process for preparing a polypeptide growth factor for milk
US5043431A (en) * 1989-09-11 1991-08-27 Codon Method and apparatus for the production of TGF-β
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
JP3386498B2 (ja) * 1992-11-06 2003-03-17 森永製菓株式会社 ヒトTGF−βの精製法
US5331095A (en) * 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
US6441152B1 (en) * 1998-12-08 2002-08-27 Boston Probes, Inc. Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
DE19918409A1 (de) * 1999-04-22 2000-10-26 Forschungszentrum Juelich Gmbh Bioreaktor umfassend einen Medienablauf und einen Rührer sowie Rührer und Medienablauf
FR2827290B1 (fr) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
US6849394B2 (en) * 2002-02-21 2005-02-01 Minitube Of America Compositions comprising reproductive cell media and methods for using such compositions
EP1728852A1 (de) * 2005-05-30 2006-12-06 Chiron Behring GmbH & Co. KG Fermentersystem für Biotechnischen Prozessen
CA2737642A1 (en) * 2008-10-06 2010-04-15 F. Hoffmann-La Roche Ag Small scale shaker flask cultivation
US10428130B2 (en) 2015-03-17 2019-10-01 Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. Purification of bone morphogenetic proteins (BMPs)
GB201509193D0 (en) 2015-05-28 2015-07-15 Ge Healthcare Bio Sciences Ab Method and system for cell cultivation
US9617191B1 (en) * 2016-06-09 2017-04-11 Xianggen Wu Bioreactor system and method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5630925A (en) * 1979-08-21 1981-03-28 Sumitomo Chem Co Ltd Purification of human growth hormone
US4296205A (en) * 1980-02-22 1981-10-20 Verma Dharmvir S Cell culture and continuous dialysis flask and method
US4427580A (en) * 1982-09-01 1984-01-24 Cornell Research Foundation, Inc. Method for separation and recovery of proteins and nucleic acids from nucleoproteins using water destructuring salts
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
US4897464A (en) * 1985-04-17 1990-01-30 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
US4751078A (en) * 1985-07-03 1988-06-14 Nagabhushan Tattanahalli L Process for the purification of gamma interferon
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
EP0268561A3 (de) * 1986-11-17 1988-10-26 Sandoz Ag Herstellung und Verwendung eines T-Zellen-Suppressorfaktors
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
EP0309111A3 (de) * 1987-09-03 1990-04-18 Invitron Corporation Verfahren zur Erzielung höherer Ausbeuten an nichtaggregiertem Gewebeplasminogenaktivator aus Zellkulturen
EP0323842A3 (de) * 1988-01-07 1990-04-25 Otsuka Pharmaceutical Co., Ltd. Methode für die Säuberung von umbildendem Wachstums-Faktor-Beta
EP0338716A3 (de) * 1988-04-21 1990-04-11 Berlex Laboratories, Inc. Methode und Vorrichtung zur Produktion nichtdegradierter Proteine aus Säugetierzellen
US5043431A (en) * 1989-09-11 1991-08-27 Codon Method and apparatus for the production of TGF-β

Also Published As

Publication number Publication date
JPH05500898A (ja) 1993-02-25
WO1991004267A1 (en) 1991-04-04
ATE140927T1 (de) 1996-08-15
DE69027995T2 (de) 1997-02-27
ES2093031T3 (es) 1996-12-16
EP0722951A2 (de) 1996-07-24
EP0491849A1 (de) 1992-07-01
AU6504490A (en) 1991-04-18
DK0491849T3 (da) 1996-12-30
US5864021A (en) 1999-01-26
EP0491849B1 (de) 1996-07-31
DE69034037T2 (de) 2003-08-28
DE69027995D1 (de) 1996-09-05
EP0491849A4 (en) 1993-04-07
ATE231165T1 (de) 2003-02-15
EP0722951B1 (de) 2003-01-15
CA2066576A1 (en) 1991-03-12
EP1132469A3 (de) 2001-11-28
DK0722951T3 (da) 2003-03-24
EP1104807A2 (de) 2001-06-06
ES2188632T3 (es) 2003-07-01
US5043431A (en) 1991-08-27
EP1132469A2 (de) 2001-09-12
EP0722951A3 (de) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69034037D1 (de) Verfahren zur Herstellung von TGF-beta
Paul et al. Serum factor requirements of normal and simian virus 40-transformed 3T3 mouse fibroblasts
MY103892A (en) Interleukin-2 of high purity production and use
Judy et al. Chemical structure and absolute configuration of a juvenile hormone from grasshopper corpora allata in vitro
EP0134385A3 (en) A protein having cell growth stimulating action, composition thereof and method for producing the same
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
AU3143589A (en) Human nerve growth factor
DE69833469D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation
TNSN88111A1 (fr) Procede de purification d'une proteine
JPH0112760B2 (de)
HK34896A (en) Novel polypeptide and production thereof
Sugimoto et al. Differential acceleration by hydrocortisone of the accumulation of epidermal structural proteins in the chick embryonic skin growing in a chemically defined medium
Sakamoto et al. Mineralization induced by β-glycerophosphate in cultures leads to a marked increase in collagenase synthesis by mouse osteogenic MC3T3-E1 cells under subsequent stimulation with heparin
US4189535A (en) Serum cell growth promoting materials
ATE66151T1 (de) Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen.
JP2500384B2 (ja) 生理活性物質の製造法
US5989880A (en) Method of preparing lysozyme dimers
DE227102T1 (de) Errichtete zellinie aus menschlichem normalem gebaermuttermuskel, verfahren zur herstellung des plasminogenaktivators mittels dieser zellinie und plasminogenaktivator.
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
AU590659B2 (en) Process for producing l-amino acids or 5'-inosinic acid by fermentation
JPH0732705B2 (ja) 動物細胞増殖用組成物およびそれを用いる動物細胞の増殖方法
MD615G2 (ro) Procedeu de cultivare a Propionibacterium freudenreichii s.s. shermanii
JPH0558706B2 (de)
Fuhr et al. Evaluation of commercial erythropoietin activity after preparative isoelectric focusing
JPS6384487A (ja) リンパ系細胞増殖用組成物及び増殖方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee